May 05, 2020 / 08:30PM GMT
Operator
Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals First Quarter 2020 Financial Results Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Jen Robinson, Vice President, Investor Relations. Thank you. Jen, go ahead.
Jennifer Robinson - Deciphera Pharmaceuticals, Inc. - VP of IR
Thank you, Frederica. Welcome, and thank you for joining us today to discuss Deciphera's first quarter 2020 financial results. I'm Jen Robinson, Vice President, Investor Relations at Deciphera. With me this afternoon to discuss the financial results and provide a general corporate update are Steve Hoerter, President and Chief Executive Officer; Matt Sherman, Chief Medical Officer; Dan Martin, Chief Commercial Officer; and Tucker Kelly, Chief Financial Officer.
Before we begin, I would like to remind you that any statements we make on this call that are not historical facts are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor
Q1 2020 Deciphera Pharmaceuticals Inc Earnings Call Transcript
May 06, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers